SMITH, GRAHAM & CO., INVESTMENT ADVISORS, LP – Eagle Pharmaceuticals, Inc. Transaction History
SMITH, GRAHAM & CO., INVESTMENT ADVISORS, LP portfolio value:
$6.13M
portfolio value
SMITH, GRAHAM & CO., INVESTMENT ADVISORS, LP quarter portfolio value change:
-40.54%
quarter
Eagle Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.14% | -322 shares | -4.19M | $26.42 | 232.02K |
| Q2 2022 | share | Decrease | -1.01% | -2.37K shares | -1.29M | $44.43 | 232.34K |
| Q1 2022 | share | Decrease | -0.65% | -1.53K shares | -414K | $49.49 | 234.72K |
| Q4 2021 | share | Decrease | -7.55% | -19.28K shares | -2.22M | $51.1 | 236.25K |
| Q3 2021 | share | Decrease | -7.94% | -22.04K shares | 2.37M | $55.78 | 255.53K |
| Q2 2021 | share | Decrease | -11.24% | -35.14K shares | -1.17M | $42.8 | 277.57K |
| Q1 2021 | share | Increase | +69.56% | 128.29K shares | 4.46M | $41.74 | 312.71K |
| Q4 2020 | share | Decrease | -1.80% | -3.37K shares | 611K | $46.57 | 184.42K |
| Q3 2020 | share | Increase | +18.36% | 29.12K shares | 365K | $42.48 | 187.79K |
| Q2 2020 | share | Increase | +5.05% | 7.62K shares | 665K | $47.98 | 158.67K |
| Q1 2020 | share | Increase | +7.88% | 11.02K shares | -1.46M | $46 | 151.04K |
| Q4 2019 | share | Decrease | -9.47% | -14.64K shares | -337K | $60.08 | 140.01K |
| Q3 2019 | share | Increase | +0.64% | 980 shares | 192K | $56.57 | 154.65K |
| Q2 2019 | share | Increase | +73.09% | 64.89K shares | 4.07M | $55.68 | 153.67K |
| Q1 2019 | share | Increase | 0.00% | 88.78K shares | 4.48M | $50.49 | 88.78K |